A significant shift in Canadian drug policy has happened, as the government announce the legalization of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were severely restricted, but a growing body of evidence suggests they could offer benefits for emotional illnesses like depression. The new policy represents a key